 Home > Encyclopedia > 7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R*,6R*,7 E,9E,11Z,13Z,15R*,17Z))-

7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R,6R,7 E,9E,11Z,13Z,15R*,17Z))-

7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R*,6R*,7 E,9E,11Z,13Z,15R*,17Z))- structure

CAS No:
95851-20-0
Formula:
C20H30O5
Chemical Name:
7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R*,6R*,7 E,9E,11Z,13Z,15R*,17Z))-
Synonyms:
7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R*,6R*,7 E,9E,11Z,13Z,15R*,17Z))-;(5S,6S,7E,9E,11Z,13Z,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid;lipoxene A;(5S,6S,7E,9E,11Z,13E,15S,17Z)-5,6,15-Trihydroxy-7,9,11,13,17-icosapentaenoic acid;7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S,6S,7E,9E,11Z,13E,15S,17Z)-;Lipoxin A5

Request for Quotation

Description

ChEBI: Lipoxin A5 is a HEPE.

7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R,6R,7 E,9E,11Z,13Z,15R*,17Z))- Basic Attributes

Molecular Weight：

350.45

Exact Mass：

350.20932405 g/mol

DSSTox ID：

DTXSID60276406

Characteristics

PSA：

98 Å²

Density：

1.112±0.06 g/cm3(Predicted)

Boiling Point：

591.3±50.0 °C(Predicted)

PKA：

4.67±0.10(Predicted)

Drug Information

MeSH Entry Terms：

5,6,15-trihydroxy-7,9,11,13,17-eicosapentaenoic acid

7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R,6R,7 E,9E,11Z,13Z,15R*,17Z))- Use and Manufacturing

Lipoxin A5 is a metabolite of EPA with effects similar to LXA4 and LXB4.

Computed Properties

Molecular Weight:350.4
XLogP3:2.5
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:13
Exact Mass:350.20932405
Monoisotopic Mass:350.20932405
Topological Polar Surface Area:98
Heavy Atom Count:25
Complexity:488
Defined Atom Stereocenter Count:3
Undefined Bond Stereocenter Count:5
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Hot Searches: raw steroid powder; food chemical suppliers; buy red phosphorus; formic acid price; magnesium nitride; enterobacter cloacae complex treatment

Guide of 7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R*,6R*,7 E,9E,11Z,13Z,15R*,17Z))-

Description
Basic Attributes
Characteristics
Drug Information
Use and Manufacturing
Computed Properties

Request for Quotation



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.